5th Antibody Generation, Engineering & Design

Venue: Frankfurt

Location: Frankfurt, Germany

Event Date/Time: Feb 27, 2012 End Date/Time: Feb 28, 2012
Report as Spam


Overcoming the challenge of developing more stable, more efficacious antibodies with reduced immunogenicity is critical to realise the potential of your pipeline and to enable product superiority. And with the recent exponential increase of interest in alternative formats, multivalent antibodies and bispecifics, there is now an unrivalled opportunity to apply that knowledge and know-how to develop truly potent antibody therapies.
At Antibody Engineering and Design, you can learn from the experts. Leading pharmaceuticals and biotechs will be sharing their experiences of designing effective antibody therapeutics enabling you to take back tried and tested methods to your lab.
Building on the huge success of our previous Antibody Engineering & Design meetings, this industry gathering again brings together the perfect blend of world beating speakers, innovative technology developers and expert scientists to meet, learn, network and debate how to progress the field. Distinct from any big biologics show where topics range from discovery to market, we will be solely focussing on the cutting-edge approaches designed to enhance therapeutic antibody potential.
Why attend?
Antibody Generation, Engineering and Design is the only meeting focused on delivering practical value to your antibody drug development activities. With speakers from leaders in the industry covering case studies and speaking openly on solutions to current problems, you’ll leave this meeting fully equipped with ideas on how to improve your own research.
Meet innovative scientists and research leaders from the world’s leading pharmaceuticals, and understand how they meet the challenges associated with engineering and designing more effective antibody drugs.

What’s covered on the agenda?
Here are just some of topics covered on the agenda:
• Innovative techniques to tackle novel target discovery
• Structural insights into antibody therapeutics
• Optimising developability during preclinical development
• Investigating novel humanisation procedures to reduce immunogenicity
• Getting an update on alternative antibody scaffolds and formats
• Cutting edge technologies to improve antibody binding and efficacy
• Learning from successful antibody blockbusters: methods to reduce time and costs

Please visit the meeting website: www.antibody-engineering.com for more information.